US Stock MarketDetailed Quotes

Kiniksa Pharmaceuticals International (KNSA)

Watchlist
  • 42.790
  • -0.260-0.60%
Close Apr 24 15:59 ET
  • 42.790
  • 0.0000.00%
Post 20:01 ET
3.29BMarket Cap57.05P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiniksa Pharmaceuticals International (KNSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
60.09%677.56M
64.95%202.13M
61.17%180.86M
44.34%156.8M
72.54%137.79M
56.60%423.24M
46.93%122.54M
67.37%112.21M
51.99%108.63M
65.18%79.86M
Operating revenue
60.09%677.56M
64.95%202.13M
61.17%180.86M
44.34%156.8M
72.54%137.79M
56.60%423.24M
46.93%122.54M
67.37%112.21M
51.99%108.63M
65.18%79.86M
Cost of revenue
62.36%307.22M
37.66%90.98M
69.10%83.56M
67.76%71.02M
96.46%61.66M
110.41%189.22M
149.16%66.09M
87.19%49.42M
95.23%42.34M
104.80%31.38M
Gross profit
58.26%370.35M
96.90%111.15M
54.93%97.29M
29.39%85.78M
57.05%76.13M
29.77%234.02M
-0.74%56.45M
54.50%62.8M
33.15%66.3M
46.80%48.47M
Operating expense
4.82%293.13M
20.64%91.38M
1.12%73.27M
-1.20%65.62M
-3.32%62.86M
36.06%279.63M
33.38%75.75M
40.49%72.46M
25.44%66.41M
47.04%65.02M
Selling and administrative expenses
16.82%196.27M
40.06%56.78M
5.83%49.1M
10.54%46.86M
12.53%43.53M
29.81%168.01M
10.33%40.54M
34.61%46.4M
45.31%42.4M
33.18%38.68M
Research and development costs
-13.23%96.85M
-1.72%34.61M
-7.26%24.17M
-21.92%18.75M
-26.62%19.33M
46.69%111.62M
75.62%35.22M
52.33%26.06M
1.05%24.02M
73.57%26.33M
Other operating expenses
----
----
----
----
----
127.00%128.31M
----
----
----
----
Operating profit
269.28%77.22M
202.43%19.77M
348.72%24.02M
17,330.77%20.16M
180.23%13.27M
-81.04%-45.62M
-23,925.93%-19.3M
11.61%-9.66M
96.29%-117K
-47.75%-16.54M
Net non-operating interest income expense
Other net income (expense)
23.07%11.65M
50.91%3.5M
27.64%3.14M
12.23%2.72M
1.19%2.29M
10.77%9.46M
-2.07%2.32M
1.19%2.46M
26.42%2.42M
23.69%2.27M
Other non- operating income (expenses)
23.07%11.65M
50.91%3.5M
27.64%3.14M
12.23%2.72M
1.19%2.29M
10.77%9.46M
-2.07%2.32M
1.19%2.46M
26.42%2.42M
23.69%2.27M
Income before tax
345.82%88.87M
237.05%23.27M
477.13%27.16M
892.93%22.88M
209.03%15.57M
-117.10%-36.15M
-793.02%-16.98M
15.27%-7.2M
285.96%2.3M
-52.46%-14.28M
Income tax
324.13%29.86M
212.10%9.07M
58.81%8.72M
-18.79%5.05M
104.96%7.03M
122.91%7.04M
64.49%-8.09M
2.54%5.49M
138.32%6.21M
17.96%3.43M
Net income
236.61%59.01M
259.75%14.2M
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
Net income continuous Operations
236.61%59.01M
259.75%14.2M
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
Minority interest income
Net income attributable to the parent company
236.61%59.01M
259.75%14.2M
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
236.61%59.01M
259.75%14.2M
245.24%18.44M
556.29%17.83M
148.23%8.54M
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
Basic earnings per share
233.33%0.8
258.33%0.19
238.89%0.25
500.00%0.24
148.00%0.12
-400.00%-0.6
-133.33%-0.12
10.00%-0.18
-128.57%-0.06
-38.89%-0.25
Diluted earnings per share
225.00%0.75
241.67%0.17
227.78%0.23
483.33%0.23
144.00%0.11
-400.00%-0.6
-134.29%-0.12
10.00%-0.18
-128.57%-0.06
-38.89%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 60.09%677.56M64.95%202.13M61.17%180.86M44.34%156.8M72.54%137.79M56.60%423.24M46.93%122.54M67.37%112.21M51.99%108.63M65.18%79.86M
Operating revenue 60.09%677.56M64.95%202.13M61.17%180.86M44.34%156.8M72.54%137.79M56.60%423.24M46.93%122.54M67.37%112.21M51.99%108.63M65.18%79.86M
Cost of revenue 62.36%307.22M37.66%90.98M69.10%83.56M67.76%71.02M96.46%61.66M110.41%189.22M149.16%66.09M87.19%49.42M95.23%42.34M104.80%31.38M
Gross profit 58.26%370.35M96.90%111.15M54.93%97.29M29.39%85.78M57.05%76.13M29.77%234.02M-0.74%56.45M54.50%62.8M33.15%66.3M46.80%48.47M
Operating expense 4.82%293.13M20.64%91.38M1.12%73.27M-1.20%65.62M-3.32%62.86M36.06%279.63M33.38%75.75M40.49%72.46M25.44%66.41M47.04%65.02M
Selling and administrative expenses 16.82%196.27M40.06%56.78M5.83%49.1M10.54%46.86M12.53%43.53M29.81%168.01M10.33%40.54M34.61%46.4M45.31%42.4M33.18%38.68M
Research and development costs -13.23%96.85M-1.72%34.61M-7.26%24.17M-21.92%18.75M-26.62%19.33M46.69%111.62M75.62%35.22M52.33%26.06M1.05%24.02M73.57%26.33M
Other operating expenses --------------------127.00%128.31M----------------
Operating profit 269.28%77.22M202.43%19.77M348.72%24.02M17,330.77%20.16M180.23%13.27M-81.04%-45.62M-23,925.93%-19.3M11.61%-9.66M96.29%-117K-47.75%-16.54M
Net non-operating interest income expense
Other net income (expense) 23.07%11.65M50.91%3.5M27.64%3.14M12.23%2.72M1.19%2.29M10.77%9.46M-2.07%2.32M1.19%2.46M26.42%2.42M23.69%2.27M
Other non- operating income (expenses) 23.07%11.65M50.91%3.5M27.64%3.14M12.23%2.72M1.19%2.29M10.77%9.46M-2.07%2.32M1.19%2.46M26.42%2.42M23.69%2.27M
Income before tax 345.82%88.87M237.05%23.27M477.13%27.16M892.93%22.88M209.03%15.57M-117.10%-36.15M-793.02%-16.98M15.27%-7.2M285.96%2.3M-52.46%-14.28M
Income tax 324.13%29.86M212.10%9.07M58.81%8.72M-18.79%5.05M104.96%7.03M122.91%7.04M64.49%-8.09M2.54%5.49M138.32%6.21M17.96%3.43M
Net income 236.61%59.01M259.75%14.2M245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M
Net income continuous Operations 236.61%59.01M259.75%14.2M245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M
Minority interest income
Net income attributable to the parent company 236.61%59.01M259.75%14.2M245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 236.61%59.01M259.75%14.2M245.24%18.44M556.29%17.83M148.23%8.54M-406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M
Basic earnings per share 233.33%0.8258.33%0.19238.89%0.25500.00%0.24148.00%0.12-400.00%-0.6-133.33%-0.1210.00%-0.18-128.57%-0.06-38.89%-0.25
Diluted earnings per share 225.00%0.75241.67%0.17227.78%0.23483.33%0.23144.00%0.11-400.00%-0.6-134.29%-0.1210.00%-0.18-128.57%-0.06-38.89%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -